Innovation

4 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 224 times.

Year	Filings
2016	1
2017	1
2018	2
2019	2
2020	4
2021	2

Investor mix

5 investors on record; lead investors include Edmond de Rothschild, Sofinnova Partners, Inno Bio Ventures.

Investor type	Count	Share
Venture capital	2	40%
Private equity	1	20%
Bank & private debt	2	40%